Recursion Provides Business Updates and Reports Fourth Quart

Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2021 Financial Results

Announced a transformational collaboration with Roche and Genentech to build and navigate maps of biology in neuroscience and an indication in gastrointestinal...

Related Keywords

Chris Gibson , Genentech , Recursion Co , Fast Track , Orphan Drug Designations , Recursion Co Founder , Recursion ,

© 2025 Vimarsana